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Background and purpose   The possibility of comparing results and 
of pooling the data has been limited for the Nordic arthroplasty 
registries, because of different registration systems and question-
naires. We have established a common Nordic database, in order 
to compare demographics and the results of total hip replacement 
surgery between countries. In addition, we plan to study results in 
patient groups in which the numbers are too small to be studied 
in the individual countries. 
Material and methods   Primary total hip replacements (THRs) 
from 1995–2006 were selected for the study. Denmark, Sweden, 
and Norway contributed data. A common code set was made and 
Cox multiple regression, with adjustment for age, sex, and diag-
nosis was used to calculate prosthesis survival with any revision 
as endpoint.
Results   280,201 operations were included (69,242 from Den-
mark, 140,821 from Sweden, and 70,138 from Norway). Females 
accounted for 60% of the patients in Denmark and Sweden, and 
70% in Norway. Childhood disease was the cause of 3.1%, 1.8%, 
and 8.7% of the operations in Denmark, Sweden, and Norway, 
respectively. Resurfacing of hips accounted for 0.5% or less in all 
countries. The posterior approach was used in 91% of cases in 
Denmark, 60% in Sweden, and 24% in Norway. Cemented THRs 
were used in 46% of patients in Denmark, in 89% of patients in 
Sweden, and in 79% of patients in Norway. 
Of the 280,201 primary THRs, 9,596 (3.4%) had been revised. 
10-year survival was 92% (95% CI: 91.6–92.4) in Denmark, 94% 
(95% CI: 93.6–94.1) in Sweden, and 93% (95% CI: 92.3–93.0) in 
Norway. In Denmark, 34% of the revisions were due to disloca-
tion, as compared to 23% in Sweden and Norway. Replacement 
of only cup or liner constituted 44% of the revisions in Denmark, 
29% in Sweden, and 33% in Norway.
 Interpretation   This unique common Nordic collaboration 
has shown differences between the countries concerning demo-
graphics, prosthesis fixation, and survival. The large number of 
patients in this database significantly widens our horizons for 
future research. 

The Nordic countries, including Denmark, Sweden, Finland, 
and Norway, have all had a long and successful tradition of 
arthroplasty registries (Herberts et al. 1989, Lucht 2000, Hav-
elin et al. 2000, Pedersen et al. 2004, Malchau et al. 2005, 
Puolakka et al. 2001).
The annual reports from the Nordic registries have indi-
cated differences between the countries concerning choices 
of  implant  brands,  fixation  methods,  and  implant  survival. 
However, because of differences in registration parameters, 
statistical methods, and patient selection, the results found in 
the annual reports from each country have not been fully com-
parable. Furthermore, the impact of the Nordic registries on 
improvements in total hip replacement (THR) surgery, which 
from an international perspective are based on relatively small 
patient populations, is inherently limited by specific demo-
graphics, implant selection, and treatment traditions. Thus, 
there is a need for collaboration across national borders to 
enable  extended  analyses  and  give  more  reliable  outcome 
data.
Knowing the limitations of registries with small populations, 
representatives  from  the  artroplasty  registries  in  Denmark, 
Finland, Norway, and Sweden met and decided to collaborate 
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data regarding THR procedures. During the process, the Finn-
ish registry decided not to participate in the present study, due 
to changes in its staff. The aim of this particular study was 
to compare demographics, choice of implant, fixation tech-
niques, and results between the 3 remaining countries. 
Materials and methods
Sources of data
The  hip  arthroplasty  registries  of  Sweden,  Denmark,  and 
Norway participated in the present study. The Swedish Hip 
Registry  was  established  in  1979,  whereas  the  Norwegian 
Arthroplasty  Registry  and  the  Danish  Hip  Registry  started 
registration in 1987 and 1995, respectively. From 1995, all 3 
registries have used individual-based registration of operations 
and patients. We therefore decided to select primary THRs 
performed during 1995–2006 for the present study. 
The databases in the 3 registers were not fully compatible, 
as we had different registration forms including somewhat 
different variables, and to some extent also different defini-
tions of variables. Thus, we defined a common set of param-
eters, containing only data that all 3 registries could deliver 
and consensus was made according to definition of several 
variables. However, for cement and prosthesis brands we kept 
the national codes unchanged but coupled them to additional 
country codes. 
Selection  and  transformation  of  the  respective  data  sets 
and de-identification of the patients, including deletion of the 
national  civil  registration  numbers,  were  performed  within 
each national registry. Anonymous data were then merged into 
a common database. 
Data were treated with full confidentiality, according to the 
rules of the respective countries. This included access to the 
common database, which was limited to the co-authors of the 
present paper. It is not possible to identify patients at an indi-
vidual level, either in this paper or in the database. 
Statistics 
Descriptive statistics and age- and sex-specific incidence rates 
for the 3 countries were calculated. Differences in patient and 
procedure characteristics between the 3 countries were tested 
using the chi-square test. A table with the 10 most commonly 
used combinations of cup and stem was constructed for each 
country, classifying the components after brand name regard-
less of other properties such as material and design. Survival 
curves were constructed by the Kaplan-Meier method, and all 
curves were ended when the number of patients at risk was 
below 100. Patients were censored at death or outcome, which-
ever came first. Outcome was any revision, defined as removal 
or exchange of at least one of the components. Only revisions 
with the primary THA recorded in the registries were included 
as outcome. We used Cox multiple regression models to assess 
survival and relative risk (RR) of any revision as endpoint, 
with 95% confidence interval (CI) and with adjustment for 
age, sex, and diagnosis. 
For  hybrids  and  uncemented THRs,  we  performed  addi-
tional time-dependent survival analyses because the country 
curves crossed each other indicating that the conditions for 
Cox regression were not fulfilled during the total time period. 
In these analyses on uncemented THRs, the follow-up after 
THR was divided into 2 periods. The first period was defined 
from the day of surgery until 5 years after surgery and the 
second period commenced at 5 years after surgery and ran 
until December 31, 2006. For hybrids, the follow-up period 
was divided at 7 years after surgery. 
The  statistics  packages  SPSS  version  15.0  (SPSS  Inc., 
Chigaco, IL) and S-Plus 7.0 (Insightful Corp., Seattle, WA) 
were used for the analyses. 
The study was approved by The Danish Data Protection 
Agency, J. no. 2008-41-2024, and by the Norwegian Social 
Science Data Services.
Results
280,201  operations  fulfilled  the  inclusion  criteria  for  the 
study (69,242 in Denmark, 140,821 in Sweden, and 70,138 
in Norway). 
Demographics
Females constituted 58% of the patients in Denmark, 60% in 
Sweden, and 70% in Norway. For male patients over the age of 
50, the incidence rate of THR was lower in Norway than in the 
other countries whereas the Norwegian female patients had the 
highest incidence rate of THR in all age groups (Table 1). 
Hip disease
Childhood diseases accounted for a larger proportion of the 
patients  in  Norway  (8.6%)  than  in  Denmark  and  Sweden 
(3.1% and 1.8%), and the proportion of patients operated due 
to idiopathic necrosis of the femoral head was higher in Den-
mark (2.8%) and Sweden (2.9%) than in Norway (1.3%). Fur-
thermore, the proportion of patients who were operated due to 
inflammatory arthritis was highest in Sweden (3.6%), slightly 
lower  in  Norway  (3.3%),  and  lowest  in  Denmark  (2.4%) 
(Table 2). 
Table 1. Age and sex-specific incidence rates from 1995–2006, of 
primary total hip arthroplasties per 100,000 inhabitants 
  Denmark   Sweden   Norway
Age   Male   Female   Male   Female   Male   Female
10–49   14   11   11   12   11   15
50–59   120   116   127   143   103   175
60–69   323   366   340   414   278   557
70–79   466   611   516   696   452   928
≥ 80   369   435   373   481   347   560Acta Orthopaedica 2009; 80 (4): 393–401  395
Prosthetic fixation technique and surgical approach 
The largest differences in surgical policies were in relation to 
fixation technique and surgical approach (Table 2). In Sweden 
and Norway, most THRs were cemented; that is, cemented 
THRs were used in 89% and 79% of the patients in these 
countries whereas they were used in only 46% of the patients 
in Denmark. 
We found that in Denmark the use of uncemented implants 
had been increasing during the study period, and the use of 
hybrids  (cemented  stem  and  uncemented  cup)  had  been 
decreasing, whereas in Sweden and Norway the use of inverse 
hybrids (uncemented stem and cemented cup) had increased. 
A posterior approach was used in 91% of the cases in Den-
mark, 60% in Sweden, and 24% in Norway. A lateral surgical 
approach, without osteotomy of the major trochanter, was the 
most common approach in Norway. A lateral approach with a 
trochanteric osteotomy was more common in Norway (3.7%) 
than in the other countries (0.9% in Denmark and 0.2% in 
Sweden). A minimally invasive incision (MIS) was uncom-
mon in all countries (2.2% in Denmark, 0.1% in Norway, and 
0.2% in Sweden).
Brands of prosthesis
We found substantial differences in choices of prosthesis brands 
between the 3 countries (Table 3). Only the Charnley/Charn-
ley (DePuy) cemented, Exeter/Exeter (Stryker) cemented, and 
Lubinus or IP (Link)/SP II (Link) cemented cup/stem combi-
nations were on the top-ten list in all 3 countries, and of the 
rest, only the combination of Reflection cemented cup/ Spec-
tron EF stem (Smith and Nephew) was among the top 10 in 
more than one of the countries. Resurfacing constituted 0.5% 
or less of the procedures in all 3 countries.
Survival and revisions (Figure 1)
Of the 280,201 primary THRs inserted during the study period, 
9,596 (3.4%) had later been revised (Table 4). The overall 10-
year survival of all THRs was 92.0% (95% CI: 91.6–92.4) in 
Denmark, 93.9% (95% CI: 93.6–94.1) in Sweden, and 92.7% 
(95% CI: 92.3–93.0) in Norway, with any revision as end-
point. The adjusted overall RR for any revision was 0.66 (95% 
CI: 0.63–0.69) and 0.84 (95% CI: 0.79–0.88) in Sweden and 
Norway compared to Denmark (Table 4). 
Sweden  had  the  highest  survival  rates  of  cemented  and 
hybrid prostheses. In patients younger than 60 years of age, 
we found better overall survival of THRs in Sweden than in 
Denmark (adjusted RR was 0.82 (95% CI: 0.75–0.90)), but it 
was not better than in Norway (adjusted RR of 0.90 (95% CI: 
0.81–1.0)) (Table 4). For patients older than 60 years of age, 
the overall survival of THRs was better in both Sweden and 
Norway than in Denmark, with adjusted RRs of 0.59 (95% CI: 
0.56–0.63) and 0.81 (95% CI: 0.77–0.87) (Table 4).
We found a 20% reduced risk of revision for uncemented 
THRs  in  Sweden  and  Norway  during  the  first  5  years  of 
follow–up, compared with Denmark (Table 5). However, if 
patients did not undergo any revision during the first 5 years 
after surgery, the survival of uncemented THRs was better in 
Denmark than in Sweden and Norway (adjusted RR was 2.15 
(95% CI: 1.63–2.83) for Sweden and 1.61 (95% CI: 1.26–
2.06) for Norway) (Table 5). The same pattern was observed 
for uncemented implants in patients less than 60 years of age 
(Table 5 and Figure 2). 
We also found better survival of hybrid THRs in Sweden and 
Norway than in Denmark within 7 years of surgery, whereas if 
patients did not undergo revision within 7 years, the survival 
of hybrid implants was again better in Denmark. 
In Denmark, 34% of revisions were due to dislocation, as 
compared to 23% in Sweden and Norway (Table 2). Replace-
ment of only the cup or liner accounted for 44% of the revi-
sions in Denmark, 29% in Sweden, and 33% in Norway (Table 
2). The percentage of extractions of the total prosthesis, tem-
Table 2. Characteristics of the total hip arthroplasty patients and 
operations registered in the NARA database, 1995–2006
  Denmark   Sweden   Norway   p-value a
No. of THAs  69,242  140,821  70,138 
Male sex, %   41.7  39.8  30.2  < 0.001
Age groups, %
   < 30 years  0.5  0.3  0.5 
   30–39  1.4  1.0  1.3 
   40–49  4.2  3.5  3.8 
   50–59  14.7  13.7  12.7 
   60–69  29.9  28.0  26.4 
   70–79  34.1  36.5  39.1 
   > 80 years  15.2   17.1  16.3  < 0.001
Diagnosis, % 
  Primary osteoarthritis  77.6  78.8  73.7 
  Inflammatory arthritis  2.4  3.6  3.3 
  Hip fracture  11.9  11.5  11.2 
  Childhood diseases  3.1  1.8  8.6 
  Idiopatic caput necrosis  2.8  2.9  1.3 
  Others  2.3  1.3  2.0   < 0.001
Fixation, % 
  Cemented  45.9  88.9  78.9 
  Uncemented  26.8  4.4  13.2 
  Hybrid  26.4  4.0  4.0 
  Inverse hybrid  0.6  2.2  3.8 
  Resurfacing  0.3  0.5  0.2  < 0.001
Approach, % 
  Posterior  91.0  60.3  23.8  < 0.001
Cause of revision, % 
  Aseptic loosening  34.8  50.4  47.3 
  Deep infection   15.8  15.0  15.5 
  Perioprostetic fracture  5.1  6.7   3.5 
  Dislocation  33.5  23.4  23.8 
  Pain only  3.0  0.8  2.3 
   Others  7.8  3.7  7.6  < 0.001
Procedure at revision, %
  Total prosthesis replaced  16.4  28.4  21.6 
  Only stem replaced  20.7  24.8  27.5 
  Only cup replaced  43.7  29.6  32.9 
  Extraction of the total   8.9  8.6  9.1 
     prosthesis
  Others  10.3  8.6  8.9  < 0.001
a Chi-square test for differences between countries.396  Acta Orthopaedica 2009; 80 (4): 393–401
porarily or permanently—which is a common treatment for 
septic  hip  prostheses—was  virtually  the  same  in  the  three 
countries.
Discussion
To the best of our knowledge, this is the first time data from 
3  national  arthroplasty  registries  have  been  successfully 
merged. The main findings in the present paper were the large 
differences between the three countries concerning prosthesis 
brands, fixation methods, and surgical approach. Thus, unce-
mented implants and the posterior approach were used more 
commonly in Denmark than in the other countries. We also 
found that more female patients and fewer male patients were 
operated in Norway than in the other countries, and that the 
proportion of patients operated due to certain hip diseases dif-
fered between the countries. Concerning prosthesis survival, 
the differences were relatively minor, but we found different 
patterns in the 3 countries concerning reasons for revision and 
procedures performed at revision. 
Demographics
We  found  different  incidences  of THR  in  the  3  countries. 
This may be due to different availability of THR, or may be 
for genetic reasons (Ingvarsson 2000). The finding of more 
female patients in Norway than in the other 2 countries is in 
accordance with the work of Lohmander et al. (2006). Fur-
thermore, we found that a greater proportion of the Norwegian 
patients were operated with THR due to childhood hip dis-
eases than in the other 2 countries. There could be a relation-
ship between these 2 findings, as dysplasia is more common in 
girls than boys. Childhood hip diseases may be more common 
in Norway, or alternatively, the diagnostics and treatment of 
these diseases in the now aging population may have been 
inferior  in  Norway  compared  to  the  other  countries  when 
these patients were children.
 The percentage of patients with avascular necrosis of the 
femoral head was low in all 3 countries compared to the rest of 
Europe and the USA, but the incidence was more than twice as 
high in Denmark and Sweden as in Norway (Mont and Hun-
gerford 1995). There may be genetic reasons for this (Zalavras 
et al. 2004). The ethnic ties between continental Europe and 
Table 3. The 10 most commonly used total hip prostheses (combination of cup/stem) in each 
country, according to brand and type of fixation
  Cup  Stem  Fixation  n
Denmark
  Lubinus/IP (Link) a  SP II (Link)  Cemented  7,652
  Exeter (Stryker)  Exeter (Stryker)  Cemented  6,779
  Trilogy (Zimmer)  Bimetric (Biomet)  Uncemented  6,299
  Trilogy (Zimmer)  Bimetric cemented (Biomet)  Hybrid   4,422
  ZCA (Zimmer)  CPT (Zimmer)  Cemented  3,233
  Universal (Biomet)  Bimetric cemented (Biomet)  Hybrid  2,912
  Müller (Biomet)  Bimetric cemented (Biomet)   Cemented  2,548
  Charnley (DePuy)  Charnley (DePuy)  Cemented  2,533
  Mallory-Head (Biomet)  Bimetric (Biomet)  Uncemented  2,400
  Mallory-Head (Biomet)  Exeter (Stryker)  Hybrid  1,628
Sweden 
  Lubinus/IP (Link) a  SP II (Link)  Cemented  48,659
  Exeter (Stryker)  Exeter (Stryker)  Cemented  15,383
  Charnley (DePuy)  Charnley (DePuy)  Cemented  14,590
  Reflection Cemented (S & N)  Spectron EF (S & N)  Cemented  6,946
  Charnley Elite (DePuy)  Exeter (Stryker)  Cemented  6,549
   FAL (LINK)  SP II (Link)  Cemented  4,059
  Contemporary (Stryker)  Exeter (Stryker)  Cemented  2,545
  Charnley (DePuy)  Exeter (Stryker)  Cemented  2,095
  OPTICUP  Scan Hip II  Cemented  1,981
  Charnley (DePuy)  Elite (DePuy)  Cemented  1,405
Norway 
  Charnley (DePuy)  Charnley (DePuy)  Cemented  22,591
  Reflection Cemented (S & N)   Spectron EF (S & N)  Cemented  6,906
   Exeter (Stryker)  Exeter (Stryker)  Cemented  6,765
  Titan (DePuy)  Titan (DePuy)  Cemented  3,943
  Lubinus/IP (Link) a  SP II (Link)  Cemented  1,394
  Tropic (DePuy)  Corail (DePuy)  Uncemented  1,711
  Igloo (Biotechni)  Filler (Biotechn)i  Uncemented  1,554
  Kronos (DePuy)  Titan (DePuy)  Cemented  1,201
  Contemporary (Stryker)  Exeter (Stryker)  Cemented   960
  Elite (DePuy)  Titan (DePuy)  Cemented  922
a Due to the coding systems, the cups IP (Link) and Lubinus (Link) were pooled. 
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Denmark and Sweden may have been closer than for Norway. 
In addition, several other factors have been recognized as risk 
factors for avascular head necrosis, including steroid therapy, 
alcohol consumption, trauma in childhood, and chemother-
apy. The impact of these factors on development of avascular 
necrosis may differ between the Nordic countries. Further-
more, alcohol drinking habits in Denmark and Sweden may 
be more similar to those of continental Europe and the USA.
 Finally, validation of hip diagnosis for primary THRs has 
been done in Denmark through review of medical records, but 
not in the 2 other countries (Pedersen et al. 2004). Thus, the 
differences in diagnosis distribution, including the high pro-
portion of childhood diseases in Norway, may also be related 
to different definitions of diagnosis and reporting in the differ-
ent countries. 
Prosthesis brands and fixation
The differences in choices of prosthesis brands in the 3 coun-
tries are difficult to explain. To a certain extent, they are prob-
ably effects of scientific evidence collected over the years, 
influenced to a greater or lesser degree by tradition and mar-
keting policies governed by the manufacturers. 
The high percentage of cemented prostheses in Sweden and 
Norway may be explained by the earlier establishment of hip 
Figure 1. Kaplan-Meier estimated curves until revision for any cause, for primary total hip replace-
ments (THAs) in Denmark, Sweden, and Norway 1995–2006. Curves are given for all THAs and 
also for those classified according to fixation technique as cemented, uncemented, and hybrids 
(uncemented cup/cemented stem). 398  Acta Orthopaedica 2009; 80 (4): 393–401
registers in these countries, compared to Denmark. There have 
been few reasons for Swedish orthopedic surgeons to change 
from cemented to uncemented prostheses, as the Swedish reg-
istry has shown good results with cemented prostheses and has 
shown that Sweden has had satisfactory results compared to 
all other countries where data is available (Herberts and Mal-
chau 1997, 2000).
In Norway, since the mid 1990s the registry has had several 
publications showing inferior results with uncemented pros-
theses, especially using the uncemented cups with UHMWPE 
liners, compared to cemented all-polyethylene cups (Havelin 
et al. 1994, 1995, 2000, 2002). Based on these publications, 
the Norwegian orthopedic surgeons stopped using the unce-
mented implants with documented inferior results, but many 
of these surgeons converted to another uncemented implant 
instead of changing over to cemented implants.
In Denmark, the orthopedic surgeons seemingly follow the 
same trends as in most continental western European countries 
and in the USA, with an increased use of uncemented prosthe-
ses during the last third of the study period. As the present 
study did not include articulation materials as a parameter, 
we cannot tell whether these uncemented prostheses included 
cups with UHMWPE liners, or if articulations based on highly 
crosslinked  polyethylene,  metal-on-metal,  or  ceramic-on-
ceramic were used. However, for modular uncemented cups 
with UHMWPE liners and a stiff metal back, there have been 
very  few,  if  any,  publications  showing  good  medium-term 
or long-term results. For some uncemented cup brands with 
UHMWPE, but with other types of metal backing than those 
predominating in the present material, the results seem to be 
better (Reigstad et al. 2008). 
Prosthetic survival
The absolute differences in survival of prostheses between the 
3 countries were minor. However, with such large numbers of 
patients as in the present study, even a 1% difference in sur-
vival at 10 years might be statistically significant.
 We found that Sweden and Norway, with their high pro-
portion of cemented prostheses, had better overall survival 
results than Denmark, which had the highest proportion of 
uncemented implants. Time-dependent analyses revealed that 
these findings applied especially to uncemented and hybrid 
Table 4. Cox regression estimates of survival probabilities and relative risk of any revision (RR) with 95% confidence intervals 
(CIs) for all THAs and according to fixation technique with adjustment for sex, age, and diagnosis, and comparing the three 
countries. Subanalyses on patients younger and older than 60 years of age are presented 
  No. of   Cox  Survival (%) K-M
  Country  THRs  Revisions  RR  95% CI  p-value   at 10 years  95% CI
All age groups        
   All THAs  Denmark  69,195  3,006  1      92.0  91.6–92.4
    Sweden  140,589  4,001  0.66  0.63–0.69  < 0.001  93.9  93.6–94.1
    Norway  69,732  2,554  0.84  0.79–0.88  < 0.001  92.7  92.3–93.0
   Cemented THAs  Denmark  31,743  1,298   1       92.9  92.4–93.4
    Sweden  124,701  3,277  0.68  0.64–0.72  <0.001  94.7  94.5–94.9
    Norway  54,709  1,823  0.90  0.84–0.97  0.005  93.5   93.2–93.9
   Uncemented THAs  Denmark  18,518  683  1      91.5  90.4–92.6
    Sweden  6,133  263  1.04  0.90–1.20  0.6  88.2  86.4–90.0
    Norway  9,142  483  0.94  0.83–1.07  0.4  89.4  88.2–90.6
   Hybrids  Denmark  18,299  1000  1      89.1  88.2–90.1
    Sweden  5,602  348  0.74  0.64–0.84  <0.001  89.8  88.5–91.1
    Norway  2,745  183  0.92  0.78–1.08  0.3  88.4  86.4–90.3
Patients < 60 years of age
   All THAs  Denmark   14,367  829  1      89.1  88.2–90.1
    Sweden  25,917  1203  0.82  0.75–0.90  <0.001  89.4  88.7–90.1
    Norway  12,745  668  0.90  0.81–1.00  0.05  88.2  87.1–89.3
   Cemented THAs  Denmark  2,303  196  1       87.5  85.6–89.4
    Sweden  15,272  643  0.68  0.57–0.79  <0.001  91.2  90.4–92.1
    Norway  4,994  241  0.89  0.73–1.08  0.2  89.1  87.3–90.8
   Uncemented THAs   Denmark  8,645  360  1      91.0  89.6–92.4
    Sweden  4,646  228  1.12  0.94–1.33  0.2  87.6   85.7–89.5
    Norway  5,388  334  0.97  0.83–1.14  0.7  88.5   87.0–90.0
Patients ≥ 60 years of age
   All THAs  Denmark  54,828  2,177  1      92.5  92.1–92.9
    Sweden  114,672  2,798  0.59  0.56–0.63   <0.001  94.9  94.7–95.2
    Norway  56,987  1,886  0.81  0.77–0.87  <0.001  93.6  93.2–94.0
   Cemented THAs  Denmark  29,440  1,102  1       93.5  93.0–94.0
    Sweden  109,429  2,634  0.68  0.63–0.73  <0.001  95.1  94.9–95.4
    Norway  49,715  1,582  0.92  0.85–0.99  0.03  93.9  93.6–94.3
   Uncemented THAs  Denmark  9,873  323  1       92.9  91.3–94.5
    Sweden  1,487  35  0.74  0.52–1.06  0.1  92.3  88.5–96.1
    Norway  3,754  149  0.94  0.77–1.16  0.6  92.5  90.8–94.2Acta Orthopaedica 2009; 80 (4): 393–401  399
implants within 5 and 7 years of surgery, whereas the results 
were opposite in the second follow-up period from 5 or 7 
years after THR surgery and beyond. This finding may be 
partly related to the higher frequency of revision in Denmark 
due to dislocations, which commonly occur within a year after 
surgery. Even so, the finding may be related to the choices of 
uncemented prosthesis brands in the 3 countries, resulting in 
different failure patterns. 
Revisions
The higher percentage of revisions due to dislocations in Den-
mark might possibly reflect the more common use of a poste-
rior approach in Denmark, compared to Sweden and Norway. 
In most publications, a higher risk of dislocation has been 
found with the posterior surgical approach than with alterna-
tive approaches (Arthursson et al. 2005). Other factors such 
as the choice of implant brand, offset, head diameter, and 
other aspects of the surgical technique, might also have had 
an effect on the dislocation rate (Byström et al. 2003, Berry et 
al. 2005). However, head diameter was not a parameter in the 
Nordic database in the present study. The higher percentage 
of exchange of cup or liner in Denmark than in Sweden and 
Norway may reflect the more extensive use of uncemented 
cups in Denmark. Liner exchange has been a common reason 
Figure 2. Kaplan-Meier estimated curves until revision for any cause, for primary cemented and 
uncemented total hip replacements (THRs) in Denmark, Sweden, and Norway 1995–2006, in 
patients younger than 60 years and in those aged 60 and older.400  Acta Orthopaedica 2009; 80 (4): 393–401
for revision in the case of uncemented cups with UHMWPE 
liners, and for some hydroxyapatite-coated uncemented cups 
there has been a high rate of revision due to aseptic loosen-
ing (Havelin et al. 2002). In the present study, however, we 
could neither differentiate liner exchange from cup exchange 
as the revision procedure, nor differentiate cup loosening from 
cup wear as the reason for revision. In future studies, we will 
address these endpoints and issues more thoroughly. 
Study model and future studies
The basis of the database used in the present study was the 
3 national databases in the respective countries that keep 
records of different parameters. When merging data into a 
common database, we could only include parameters that all 
3 registries could contribute. Thus, the Nordic database is 
not as rich in detail as each separate database. Furthermore, 
for similar reasons, we could not include THRs from before 
1995, which imposed limitations in the length of follow-up-
time. On the other hand, the strength of this Nordic project is 
that we, for the first time, can directly compare the descrip-
tive statistics and the survival results of THRs between three 
countries. The Nordic project may be looked upon as a start 
on the long way to assisting in the development of standard-
ized registry data and approaches to analysis, which could 
help in developing cooperation between registries interna-
tionally in the future. 
We used survival analysis with adjustment for demographic 
differences rather than revision burden, as we believe that the 
use of survival analysis is a more accurate way of presenting 
and comparing the results of THR surgery. As described in 
an annual report from the Danish Hip Arthroplasty Registry 
(Annual Report 2007, www.dhr.dk), the term revision burden 
can be defined in at least three different ways. For the time 
being, there is no consensus on definition of revision burden 
between European national registries. By using survival anal-
ysis, we are able to avoid definition issues. In addition, the 
rapidly increasing amount of prosthesis surgery in some coun-
tries, with accordingly small numbers of prostheses with long 
follow-up in the population, would have a large effect on revi-
sion burdens. Revision burdens might thus be frequently inac-
curate and misleading, and they should be used with caution 
and only be presented together with thorough explanations 
of their flaws. Nevertheless, in comparing national results by 
means of survival analysis or revision burdens, the data should 
be collected, selected, and validated similarly in the different 
countries—and these data should preferably be pooled before 
national results are assessed and compared.
For  all  the  national  registries  that  delivered  data  to  the 
common Nordic database, there is documentation on the high 
degree of completeness, which reduces the selection bias and 
increases the generalizability of the results (Sødermann 2000, 
Pedersen et al. 2004, Arthursson et al. 2005, Espehaug et al. 
2006).
As there appears to be a tendency for most orthopedic sur-
geons to follow the most accepted surgical policies in their 
respective countries, there have been limitations within each 
country  on  comparing  the  mainstream  treatment  with  the 
alternative treatments that might have been used in smaller 
numbers of patients. As mentioned above, however, concern-
ing surgical approach and the use of uncemented implants, 
the  mainstream  treatment  differs  between  the  3  countries. 
Thus, regarding future studies, we look forward to comparing 
results with satisfactory statistical strength, between groups 
of patients that would be too small to study in each country 
alone. It would also be interesting to compare the different 
national results with a particular commonly used prosthesis 
brand, such as the Charnley, Exeter, Lubinus/SP II, or Reflec-
tion cemented/Spectron. Such studies could probably provide 
an indication of the quality of surgery per se, and of the quality 
of education programs for orthopedic surgeons in training.
 With this Nordic database, we also plan to follow the results 
of new treatments such as resurfacing prostheses and articula-
Table 5. Cox regression estimates of survival, and relative risk of any revision (RR) with 95% confidence 
intervals (CIs), according to time-dependent covariates (follow-up < 5 years or ≥ 5 years for unce-
mented THAs, and follow-up < 7 years or ≥ 7 years for hybrids), for all age groups and for patients less 
than 60 years of age 
  RR  95% CI  p-value  RR  95% CI  p-value
Uncemented THA, all age groups:  Follow-up < 5 years      Follow-up ≥ 5 years      
  Denmark  1         1  
  Sweden  0.79   0.66–0.95  0.013  2.15  1.63–2.83  < 0.001
  Norway  0.80  0.69–0.93  0.003  1.61  1.26–2.06  < 0.001
Hybrids, all age groups:  Follow-up < 7 years    Follow-up ≥ 7 years      
  Denmark   1        1  
   Sweden  0.59  0.50–0.68  < 0.001  1.48  1.15–1.92  0.003
    Norway  0.83  0.69–1.00  0.051  1.47  1.05–2.06  0.03
Uncemented THA, age < 60 years:  Follow-up < 5 years    Follow-up ≥ 5 years   
  Denmark  1       1  
   Sweden  0.86  0.62–0.93  0.007  1.96  1.45–2.64   < 0.001
    Norway  0.76  0.69–0.93  0.2  1.60  1.22–2.10  0.001Acta Orthopaedica 2009; 80 (4): 393–401  401
tions without UHMWPE, and the results of THRs in smaller 
age groups or diagnostic groups.
 Prostheses of the knee and patients treated with prosthe-
ses due to proximal femoral fractures will also be subjects for 
future studies. In these studies, we expect that Finland will 
also join in. 
Conclusion
This unique collaboration of the Nordic national orthopedic 
databases is now functional, with three countries participat-
ing so far, and it has shown that there are differences between 
the countries concerning demographics, prosthesis fixation, 
prosthesis survival, and revision patterns. The large numbers 
of patients in this database widens our horizons for future 
research, and we expect that this new register will become a 
valuable tool in our future research with the aim of improving 
the quality of joint replacement surgery. 
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